News
Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about taking branded GLP-1s.
Shares of Hims & Hers Health skyrocketed to 40% in the premarket following the telehealth company’s partnership announcement ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
22h
Philstar Life on MSNObesity therapies you should knowI understand how it feels to be bullied because of one’s weight. I have been there. However, at that time, I was also ...
Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...
Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results